AG
PGNX
Aperio Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-17,170
| Closed | -$65K | – | 2424 |
|
|
2020
Q1 | $65K | Sell |
17,170
-9,606
| -36% | -$36.4K | ﹤0.01% | 2258 |
|
|
2019
Q4 | $136K | Sell |
26,776
-556
| -2% | -$2.82K | ﹤0.01% | 2246 |
|
|
2019
Q3 | $138K | Sell |
27,332
-6,511
| -19% | -$32.9K | ﹤0.01% | 2217 |
|
|
2019
Q2 | $209K | Buy |
33,843
+4,378
| +15% | +$27K | ﹤0.01% | 2161 |
|
|
2019
Q1 | $137K | Sell |
29,465
-407
| -1% | -$1.89K | ﹤0.01% | 2213 |
|
|
2018
Q4 | $125K | Buy |
+29,872
| New | +$125K | ﹤0.01% | 2203 |
|
|
2018
Q1 | – | Sell |
-16,653
| Closed | -$99K | – | 2281 |
|
|
2017
Q4 | $99K | Buy |
16,653
+584
| +4% | +$3.47K | ﹤0.01% | 2210 |
|
|
2017
Q3 | $118K | Buy |
+16,069
| New | +$118K | ﹤0.01% | 2177 |
|